Results 111 to 120 of about 12,163 (174)

Optimal antithrombotic therapy for patients with atrial fibrillation and prior stent. [PDF]

J Thorac Dis
Botros M, Mani S, Mukherjee D.
europepmc   +1 more source

The use of direct oral anticoagulants in children with congenital and acquired heart disease. [PDF]

Front Cardiovasc Med
Abdelghani E, Thakkar M, Berthiaume J, Ahuja S.   +3 more
europepmc   +1 more source

Residue‑resolved dynamically averaged interaction analysis of direct factor Xa inhibitors by MD‑FMO combination calculations. [PDF]

J Comput Aided Mol Des
Yoshine R, Hirano Y, Doi H, Kitahara S, Akisawa K, Okuwaki K, Yamamoto E, Yasuoka K, Mochizuki Y.   +8 more
europepmc   +1 more source

Edoxaban for Stroke Prevention in Atrial Fibrillation in Spain and Portugal: 4-Year Follow-Up of the Observational ETNA-AF-Europe Study. [PDF]

J Clin Med
Barón-Esquivias G, Monteiro P, Santiago-Ruiz JL, Basterra-Trincado L, Vieira Dos Santos L, Ruivo J, Fronk EM, Kirchhof P, De Caterina R.   +8 more
europepmc   +1 more source

Real-world bleeding risk and molecular interaction profiles of direct oral anticoagulants: a comparative study integrating clinical outcomes and <i>in silico</i> docking. [PDF]

Front Pharmacol
Onar LC, Guner E, Yilmaz I.
europepmc   +1 more source

Integrating pharmacovigilance and machine learning: bleeding signal detection and risk prediction for oral anticoagulants in cancer patients. [PDF]

Res Pract Thromb Haemost
Lv M, Zheng X, Xie H, Lin B.
europepmc   +1 more source

Direct Oral Anticoagulants Versus Phenprocoumon: Mortality, Thromboembolism and Major Hemorrhage. A Systematic Review and Meta-Analysis of Routine Data Studies. [PDF]

Dtsch Arztebl Int
Engelbertz C, Reinecke H, Köppe J.
europepmc   +1 more source

Agent-specific bleeding signatures in non-hypertensive versus hypertensive patients exposed to oral anticoagulants: a real-world pharmacovigilance study. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Feng Y, Liu HH, Li LC, Mao KL, Niu XF, Hu J.   +5 more
europepmc   +1 more source

Edoxaban for atrial fibrillation in patients with atherosclerotic disease in daily clinical practice. [PDF]

J Thromb Thrombolysis
de Vries TAC, de Groot JR, Pisters R, Hemels MEW, Komen JJ, Smolnik R, Fronk EM, Steffel J, Weiss T, de Asmundis C, Kirchhof P, De Caterina R.   +11 more
europepmc   +1 more source

Risk of intracranial hemorrhage with direct oral anticoagulants: an updated network meta-analysis of randomized controlled trials. [PDF]

Front Cardiovasc Med
Chen J, Chen Q, Guan C, Xia J.
europepmc   +1 more source